Solventum Co. (NYSE:SOLV) Stock Holdings Lessened by Birmingham Capital Management Co. Inc. AL

Birmingham Capital Management Co. Inc. AL lessened its holdings in shares of Solventum Co. (NYSE:SOLV) by 58.3% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,930 shares of the company’s stock after selling 4,096 shares during the period. Birmingham Capital Management Co. Inc. AL’s holdings in Solventum were worth $204,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of SOLV. Davis Selected Advisers acquired a new position in Solventum in the second quarter valued at approximately $273,070,000. Nuance Investments LLC bought a new stake in shares of Solventum in the 2nd quarter worth approximately $115,829,000. Newport Trust Company LLC acquired a new position in Solventum during the 2nd quarter valued at approximately $98,976,000. Baupost Group LLC MA acquired a new stake in Solventum in the second quarter worth $96,242,000. Finally, Hotchkis & Wiley Capital Management LLC bought a new stake in Solventum in the third quarter valued at $125,488,000.

Analyst Upgrades and Downgrades

Several research firms have recently commented on SOLV. Wolfe Research began coverage on shares of Solventum in a research report on Thursday, September 26th. They set a “peer perform” rating for the company. Stifel Nicolaus assumed coverage on shares of Solventum in a research report on Tuesday, October 8th. They issued a “buy” rating and a $82.00 target price for the company. Piper Sandler boosted their price objective on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a research report on Friday, November 8th. Mizuho initiated coverage on Solventum in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $70.00 target price on the stock. Finally, Morgan Stanley increased their price target on Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research note on Monday, November 11th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $68.29.

Solventum Stock Performance

Shares of SOLV traded down $0.94 during midday trading on Friday, hitting $69.07. The stock had a trading volume of 125,811 shares, compared to its average volume of 1,638,977. The business has a 50-day simple moving average of $70.87 and a two-hundred day simple moving average of $63.13. Solventum Co. has a fifty-two week low of $47.16 and a fifty-two week high of $96.05. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.83 and a current ratio of 1.15.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.